apr 102017


Dottorato di Ricerca in Biotecnologie Industriali

mercoledì 26 aprile 2017, ore 14:00, aula U4-08, edificio U4

Dr. Giulia Callegaro (Doctor Europaeus)
“Fostering Cell Transformation Assay in carcinogenicity assessment: toward in vitro-in silico bridging”

Dr. Damiano Pellegrino Coppola (Doctor Europaeus)
“Acetyl-Coa metabolism and aging: risks and resources”

Dr. Cristina Visentin (Doctor Europaeus)
“Use of a technological platform to screening in vitro and in vivo anti-amyloidogenic drugs able to prevent early neurodegenerative process ”

Dr. Marco Viganò
“ Mesenchymal stem cells for the treatment of musculoskeletal pathologies: focus on tendinopathy”

Dr. Daniele Cesena
“The RNA processing proteins Xrn1 and Rrp6 regulate DNA damage checkpoint activation and telomere metabolism”

giovedì 27 aprile 2017, ore 9:00, aula U6-04, edificio U6

Dr. Alessia D’Aloia
“RalGPS2 interacts with LST1 and supports tunneling nanotubes formation in human bladder cancer cells”

Dr. Gaia De Sanctis (Doctor Europaeus)
“An integrated approach to study Ras-dependent cancer metabolic rewiring in mouse fibroblasts”

Dr. Mara Gilardi (Doctor Europaeus)
“Dissecting the critical role of cancer/endothelial interactions in metastatic cascade through engineered 3D vascularized microfluidic and mesoscale models”

Dr. Michela Bellini
“Development of apoferritin nanoparticles for chemotherapeutic delivery and drug resistance overcoming in breast cancer models”

Dr. Francesca Ricciardiello
“FR051, a novel Hexosamine Biosynthetic Pathway inhibitor, induces cell death in breast and pancreatic cancer models”

scarica la locandina

Sorry, the comment form is closed at this time.